CalciMedica, Inc.(CALC)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
CALC is scheduled to report on Nov 10, 2026, usually before the market opens. Analysts expect EPS of -$1.30.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±6.0%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 6 misses.
In plain words: it beat expectations 5 times, but the stock still fell 2 of those 5 times.
- May '26Beat▲ +6.6%
- Mar '26Missed▲ +14.4%
- Nov '25Missed▲ +4.0%
- Aug '25Missed▼ -10.1%
- May '25Missed▼ -0.9%
- Mar '25Missed▲ +4.0%
- Nov '24Missed▼ -2.6%
- Aug '24Beat▼ -3.6%
- May '24Beat▲ +6.7%
- Mar '24Beat▼ -5.5%
- Nov '23Beat▲ +7.1%
Clear beats and misses with a known reaction only. What counts as a beat
Why did CALC fall after beating earnings?
5 of CALC's last 11 reactions went against the EPS result. What stands out in each:
CALC beat EPS estimates in 5 quarters, and the stock still closed lower the next day 2 times.
- Aug 12, 2024EPS beat +31.6%stock -3.6% next day
- It had risen 9.3% in the final week before the report, so good news may already have been priced in.
- Mar 28, 2024EPS beat +77.0%stock -5.5% next day
- It had risen 8.6% in the final week before the report, so good news may already have been priced in.
Rose despite an EPS miss (3 of 6)
- Mar 3, 2026EPS missed -67.5%stock +14.4% next day
- It had already fallen 43.7% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 10.5% higher as soon as trading resumed.
- Nov 12, 2025EPS missed -26.2%stock +4.0% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Mar 27, 2025EPS missed -246.6%stock +4.0% next day
- It had already fallen 13.9% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 11.1% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was CALC's earnings move already priced in?
CALC's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does CALC hold its opening gap after earnings?
CALC's opening move after each report and where it closed that day.
In 7 reports CALC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 7 times (43%), and fully reversed 2 times. Gaps up faded 2 of 5; gaps down recovered 1 of 2.
- May 12, 2026HeldOpened +4.2%, closed +6.6%
- Mar 3, 2026HeldOpened +10.5%, closed +14.4%
- Aug 12, 2025HeldOpened -3.6%, closed -10.1%
- May 14, 2025ReversedOpened +1.6%, closed -0.9%
- Mar 27, 2025FadedOpened +11.1%, closed +4.0%
- May 13, 2024ReversedOpened -2.5%, closed +6.7%
- Nov 9, 2023HeldOpened +3.2%, closed +7.1%
What the history says
- It fell after 2 of its 5 EPS beats (40%): beating estimates has not been enough on its own.
CALC earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Before open | -$1.45 | -$2.25 | -55.2% | — | — |
| May 12, 2026 | Before open | -$1.40 | $1.50 | +207.1% | +6.60% | +15.06% |
| Mar 3, 2026 | Before open | -$2.06 | -$3.45 | -67.5% | +14.40% | +30.37% |
| Nov 12, 2025 | Before open | -$2.06 | -$2.60 | -26.2% | +4.05% | -6.54% |
| Aug 12, 2025 | Before open | -$1.75 | -$2.00 | -14.3% | -10.14% | -5.43% |
| May 14, 2025 | Before open | -$1.50 | -$1.80 | -20.0% | -0.88% | +3.63% |
| Mar 27, 2025 | Before open | -$1.76 | -$6.10 | -246.6% | +4.02% | -4.02% |
| Nov 13, 2024 | Before open | -$2.48 | -$2.50 | -0.8% | -2.58% | -4.58% |
| Aug 12, 2024 | After close | -$2.63 | -$1.80 | +31.6% | -3.63% | -12.39% |
| May 13, 2024 | After close | -$3.70 | $0.05 | +101.4% | +6.73% | +4.42% |
| Mar 28, 2024 | After close | -$5.00 | -$1.15 | +77.0% | -5.53% | +0.60% |
| Nov 9, 2023 | After close | -$5.70 | -$4.10 | +28.1% | +7.11% | +7.87% |
Consensus for the next report: EPS -$1.30, revenue $0.00.
CALC Earnings FAQ
Answers computed from CalciMedica, Inc.'s reported history
CALC is scheduled to report on Nov 10, 2026, usually before the market opens. Analysts expect EPS of -$1.30.
Over the last 12 quarters with a usable EPS surprise, CALC beat the consensus estimate 5 times (42%), missed 7 and landed in line 0.
Across its last 11 quarters with a measured reaction, CALC moved an average of ±6.0% in the first session after reporting. It closed higher 55% of the time; the largest gain was 14.4% and the largest drop -10.1%.
CALC fell in the first session after 2 of its last 5 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 11 quarters with price data, CALC moved an average of +2.6% in the 20 trading sessions before reporting and was higher in 36% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging +0.7%. After a drop of 3% or more (5 quarters), it rose the next day 60% of the time, averaging +3.4%. This describes past reports; it is not a forecast.
In 7 reports CALC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 7 times (43%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · CALC: 12 reported quarters, latest Aug 11, 2026. Information only, not investment advice.
Looking for more on CALC?
Price charts, forecast, fundamentals and risk pages for CALC are not on Tickzen yet. You can run a full stock analysis now.
Run the CALC Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun